Anthea Pisani
YOU?
Author Swipe
View article: P0738 Apulian Network for Inflammatory Bowel Disease (AN-IBD) safety profile: Pilot data
P0738 Apulian Network for Inflammatory Bowel Disease (AN-IBD) safety profile: Pilot data Open
Background The Apulian Network for Inflammatory Bowel Disease (AN-IBD) is a prospective observational regional database recently approved by the Ethics Committee in Apulia (Italy), enrolling all IBD patients with an established diagnosis a…
View article: Endoscopic retrograde cholangiopancreatography training conditions, results from a pan‐European survey: Between vision and reality
Endoscopic retrograde cholangiopancreatography training conditions, results from a pan‐European survey: Between vision and reality Open
Background Endoscopic retrograde cholangiopancreatography (ERCP) still has a relatively high complication rate, underscoring the importance of high‐quality training. Despite existing guidelines, real‐world data on training conditions remai…
View article: Shedding a new light on gastric cancer screening
Shedding a new light on gastric cancer screening Open
Early accurate detection of gastric cancer, which is the fourth most common malignancy worldwide,1 significantly improves morbidity and mortality. Whilst the 5 years relative survival risk of gastric cancer is 35.7%,2 when diagnosed at an …
View article: Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean
Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean Open
Background Microbial communities have long been suspected to influence inflammatory processes in the gastrointestinal tract of patients with inflammatory bowel disease. However, these effects are often influenced by treatments and can rare…
View article: The upward trajectory of the UEG journal: Next Generation Trainee Editors
The upward trajectory of the UEG journal: Next Generation Trainee Editors Open
Nine females and six males from Europe and beyond: a quintet of Italians among two English, two Dutch, one German, one Iranian, one Czech, one Portuguese, one Maltese and one Turkish. Our group consists of basic scientists, clinical resear…
View article: An Updated Comparative Study on the Impact of COVID-19 Infection and Vaccination in Patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome
An Updated Comparative Study on the Impact of COVID-19 Infection and Vaccination in Patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome Open
Background and Aims: This study assessed the differences in swabbing rates, vaccine uptake, COVID-19 infection, hospitalization rates and outcomes in patients suffering from inflammatory bowel disease (IBD) on immunomodulation and patients…
View article: Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey. Open
Although IBD patients raised concerns about the safety and efficacy of anti-SARS-CoV-2 vaccines, the implementation of vaccination in those responding to our survey was high and the adverse events were comparable to the general population,…
View article: Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission Open
Dysbiosis in inflammatory bowel disease (IBD) has been implicated as a causal or contributory factor to the pathogenesis of the disease. This study, done on patients in remission while accounting for various confounding factors, shows sign…
View article: Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey Open
Introduction Anti-SARS-CoV-2 vaccine clinical trials did not include patients with immune-mediated conditions such as inflammatory bowel disease [IBD]. We aimed to describe the implementation of anti-SARS-CoV-2 vaccination among IBD patien…
View article: P307 The effect of COVID-19 infection and vaccination in patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome
P307 The effect of COVID-19 infection and vaccination in patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome Open
Background Inflammatory Bowel Disease(IBD) and Irritable Bowel Syndrome(IBS) are gastrointestinal disorders which differ in pathophysiology and management. The use of immunomodulatory drugs brings concerns which increased during the pandem…
View article: Supplementary Material for: Significant differences in IBD care and education across Europe: results of the pan-European VIPER survey
Supplementary Material for: Significant differences in IBD care and education across Europe: results of the pan-European VIPER survey Open
Background: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries. Methods: Thi…
View article: P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey
P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey Open
Background Pivotal anti-SARS-CoV-2 vaccines clinical trials did not include patients with immune-mediated conditions such as inflammatory bowel disease (IBD). We aimed to describe the implementation of anti-SARS-CoV-2 vaccines among IBD pa…
View article: HMO-1 Variation in IBD care and education across Europe results from a pan-European survey
HMO-1 Variation in IBD care and education across Europe results from a pan-European survey Open
Background 2.5 million people in Europe are diagnosed with IBD. IBD affects quality of life, but also has important consequences for health systems. It remains unknown if there are variations in IBD care across Europe and to help address t…
View article: P688 Association of Akkermansia muciniphila with a healthy gut microbiome
P688 Association of Akkermansia muciniphila with a healthy gut microbiome Open
Background Comprehensive knowledge of the types and ratios of microbes present in the healthy gastrointestinal human gut is required before any study is attempted to alter the microbiome to treat one condition. Akkermansia muciniphila, a m…
View article: DOP25 Association of Enterobacteriaceae with Crohn’s Disease subtypes during remission
DOP25 Association of Enterobacteriaceae with Crohn’s Disease subtypes during remission Open
Background Members of the Enterobacteriaceae have been associated with active Crohn’s Disease (CD), possibly as a result of intestinal inflammation via production of a lipopolysaccharide that can trigger TLR4 signalling. This study aims to…
View article: P685 Gut microbiota in patients with Inflammatory Bowel Disease during remission
P685 Gut microbiota in patients with Inflammatory Bowel Disease during remission Open
Background Dysbiosis in patients with active IBD has been described in many studies and populations. There is, however, minimal data on whether dysbiosis persists during remission and the extent to which it does. The aim of this study was …
View article: Prevalence, Behaviours and Burden of Irritable Bowel Syndrome in Medical Students and Junior Doctors.
Prevalence, Behaviours and Burden of Irritable Bowel Syndrome in Medical Students and Junior Doctors. Open
IBS is prevalent, yet under-recognized, in medical students and junior doctors. Measures should be instituted for timely, confidential detection and management of IBS and its related psychological consequences.
View article: The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training
The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training Open
Introduction: The SARS-CoV-2 (COVID-19) pandemic has brought about a radical change in our working patterns. These changes can affect the training that gastroenterology trainees undergo, especially endoscopy since these are aerosol-generat…
View article: Supplementary Material for: The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training
Supplementary Material for: The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training Open
Introduction: The SARS-CoV-2 (COVID-19) pandemic has brought about a radical change in our working patterns. These changes can affect the training that gastroenterology trainees undergo, especially endoscopy since these are aerosol-generat…
View article: European Specialty Examination in Gastroenterology and Hepatology examination — improving education in gastroenterology and hepatology
European Specialty Examination in Gastroenterology and Hepatology examination — improving education in gastroenterology and hepatology Open
European Specialty Examination in Gastroenterology and Hepatology examination — improving education in gastroenterology and hepatology